ClinicalTrials HQ

An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma

An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma

Recruiting · NCT06668792 · Registry updated 2025-02-04
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 22025-02-04NCT06668792

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Biocad24

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Branch of the limited liability company "Hadassah Medical LTD"MoscowRussia1
City Clinical Hospital №52 of the Department of Health of the City of MoscowMoscowRussia1
Federal State Budgetary Institution "National Medical Research Center for Radiology" of the Ministry of Health of the Russian FederationObninskRussia3
FSBEI HE "Saratov State Medical University named after V.I. Razumovsky" of the Ministry of Health of RussiaSaratovRussia2
FSBEI of Higher Education "Bashkir State Medical University" of the Ministry of Health of the Russian FederationUfaRussia1
FSBEI of Higher Education "Samara State Medical University" of the Ministry of Health of the Russian FederationSamaraRussia2
FSBI "Almazov National Medical Research Centre" of the Ministry of Health of the Russian FederationSaint PetersburgRussia1
FSBI "National Medical Research Center of Oncology named after N. N. Blokhin" of the Ministry of Health of the Russian FederationMoscowRussia2
FSBI of science "Kirov research Institute of Hematology and blood transfusion of the Federal medical and biological Agency"KirovRussia1
JSC "Medsi Group of Companies"MoscowRussia1
Private healthcare institution "Clinical hospital "RZD-Medicine" of the city of Smolensk"SmolenskRussia2
Public institution "Komi Republican cancer clinic"SyktyvkarRussia1
Regional Government-Owned Publicly Funded Healthcare Institution "Regional Clinical Hospital"KrasnoyarskRussia2
SAHI "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigala"Kazan'Russia1
SBHI of the Kaliningrad region "Central City Clinical Hospital"KaliningradRussia1
SBHI of the Republic of Karelia "Republican Hospital named after V.A. Baranov"PetrozavodskRussia1
SBI of health care of the city of Moscow city clinical hospital named after S. P. Botkin of the Department of health of the City of MoscowMoscowRussia1
State Budgetary Healthcare Institution "Oncological Dispensary No.2" of the Ministry of Health of the Krasnodar RegionSochiRussia2
State budgetary healthcare Institution of the Moscow Region "Moscow Regional Research Clinical Institute named after M. F. Vladimirsky"MoscowRussia1
State budgetary healthcare institution of the Sverdlovsk region "Sverdlovsk regional clinical hospital №1"YekaterinburgRussia1